Advertisement

Organ Preservation for Advanced Head and Neck Cancer Concomitant Chemoradiation

  • Bruce Brockstein
Part of the Cancer Treatment and Research book series (CTAR, volume 114)

Conclusion

Treatment options for patients with locoregionally advanced head and neck cancer are now diverse. Surgery plus radiation or surgery plus chemoradiation remain options for patients with resectable disease. The same patients, however, appear to have an equally efficacious option of concomitant chemoradiation, with surgery reserved for salvage only. When performed in experienced settings, non-comparative data seem to indicate the outcome to be equivalent or perhaps even better. Direct comparisons between surgery and chemoradiation are unavailable. These would be extremely useful in terms of understanding optimal treatment, both in terms of cure, organ preservation, function preservation, and quality of life. All patients referred for resection of locoregionally advanced head and neck cancer should also have the option of concomitant chemoradiation discussed if an experienced treatment group is available to the patient.

Keywords

Neck Cancer Induction Chemotherapy Radiat Oncol Biol Phys Radiation Therapy Oncolgy Group Organ Preservation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual patient data. Lancet 2000;355:949–955.PubMedGoogle Scholar
  2. 2.
    Munro, A. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995; 71:83–91.PubMedGoogle Scholar
  3. 3.
    El-Sayed, S, Nelson, N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials. J Clin Oncol 1996; 14:838–847PubMedGoogle Scholar
  4. 4.
    Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Cancer Study Group. N Engl J Med 1991; 324:1685–1690.Google Scholar
  5. 5.
    Lefebvre, JL, Chevalier, D, Luboinski, B, et al. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for research of cancer phase II trial. J Natl Cancer Inst 1996; 88:890–899.PubMedGoogle Scholar
  6. 6.
    Forastiere AA, Berkey B, Maor M, et al. Phase III trial to preserve the larynx: Induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versusu radiotherapy alone, Intergroup trial R91-11. Proc ASCO 2001;20:abstract 4.Google Scholar
  7. 7.
    Ku KK, Pajak TF, Trotti A, et al. A radiation therapy oncolgy group (RTOG) phase III randomized study to compare hyperfractionated and two variants of accelerated fractionation to standard fractionated radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiation Oncology Biol Phys 2000;48:7–16.Google Scholar
  8. 8.
    Merlano M, Benasso M, Corvo R, et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996;88:583–589.PubMedGoogle Scholar
  9. 9.
    Roh HD, Boucher Y, Kalnicki S, et al: Interstitial hypertension in carcinoma of uterine cervix in patients: Possible correlation with tumor oxygenation and radiation response. Cancer Res 1991; 51:6695PubMedGoogle Scholar
  10. 10.
    Bush RS, Jenkin RDT, Alh WEC et al: Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 1978; 38(suppl 3):302Google Scholar
  11. 11.
    Weichselbaum RR, Little JB: Repair of potentially legal x-ray damage and possible applications to clinical radiotherapy. Int J Radiat Oncol Biol Phys 1993; 9:91Google Scholar
  12. 12.
    Kinsella TJ: Radiosensitization and cell kinetics: Clinical implications for s-phase-specific radiosensitizers. Semin Oncol 1992; 19(suppl 9):41PubMedGoogle Scholar
  13. 13.
    Laramore GB, Scott CB, Al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup study 0034. Int J Radiat Oncol Biol Phys 1992;23:705–713.PubMedGoogle Scholar
  14. 14.
    Paccagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppodidi Studio SUI Tumori Della Testa E Del Collo. J Natl Cancer Inst 1994;86:265–272.PubMedGoogle Scholar
  15. 15.
    Schuller DE, Laramore G, Al-Sarraf M, Jacobs J, Pajak T. Combined therapy for resectable head and neck cancer. A phase III intergroup study. Arch Otolaryngol Head Neck Surg 1989;115:364–368.PubMedGoogle Scholar
  16. 16.
    Head and Neck Contracts Program. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the head and neck contracts program. Cancer 1987;60:301–311Google Scholar
  17. 17.
    Adelstein DJ, Lavertu P, Saxton JP et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000;88:876–883.PubMedCrossRefGoogle Scholar
  18. 18.
    Adelstein DJ, Saxton JP, Lavertu P, et al. Maximizing local control and organ preservation in advanced squamous cell head and neck cancer (SCHNC) with hyperfractionated radiation (HRT) and concurrent chemotherapy. Proc ASCO 2001;20:224a, abstract 893.Google Scholar
  19. 19.
    Wendt TG, Grabenbauer GG, Rodel CM. Simultaneous radiotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 16:1318–1324Google Scholar
  20. 20.
    Brizel DM, Albers ME, Fisher R, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798–1804.PubMedCrossRefGoogle Scholar
  21. 21.
    Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low dose cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 2000;18:1458–1464PubMedGoogle Scholar
  22. 22.
    Calais G, Alfonsi M, Bardet E et al. Randomized trial of radiation versus concomitant chemotherapy and radiation for advanced-stage oropharynx carcinoma, J Natl Cancer Inst 1999; 15:2081–2086.Google Scholar
  23. 23.
    Vokes EE, Kies M, Haraf DJ, et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 2000; 18:1652–1661.PubMedGoogle Scholar
  24. 24.
    Kies MS, Haraf DJ, Rosen F, et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 2001;19:1961–1969.PubMedGoogle Scholar
  25. 25.
    Rosen FR, Haraf DJ, Brockstein B, et al. Multicenter randomized phase II study of 1-hour infusion paclitaxel, fluorouracil and hydroxyurea with concomitant hyperfractionated radiotherapy (2XRT) with or without erythropoietin for advanced head and neck cancer. Proc ASCO 2001;20:226a, abstract 902Google Scholar
  26. 26.
    Glicksman AS, Wanebo HJ, Slotman G, et al. Concurrent platinum based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1997;39:721–729.PubMedCrossRefGoogle Scholar
  27. 27.
    Leyvraz, S, Pasche, P, Bauer, J, et al. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma; Four year results of a phase I/II study. J Clin Oncol 1994; 12:1876.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Bruce Brockstein
    • 1
    • 2
  1. 1.Evanston Northwestern HealthcareEvanston
  2. 2.Northwestern UniversityChicago

Personalised recommendations